文献速递类风湿关节炎

CXCR5/CXCL13通路是调节性B10细胞迁移的关键驱动因素,在类风湿关节炎患者中存在缺陷

CXCR5/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该研究比较了健康供者与RA患者B10+与B10neg细胞的趋化因子受体表达谱,发现CXCR5在B10+细胞表面高表达,其配体CXCL13优先吸引B10+细胞并促进B细胞分泌IL-10。RA患者B细胞表面CXCR5水平降低,B10+细胞向富含CXCL13的滑液迁移的优先性丧失,且CXCL13刺激诱导的IL-10分泌减少。结论提示CXCR5/CXCL13轴对B10+细胞生物学至关重要,但在RA中功能缺陷。

要点

  • CXCR5在B10+细胞表面表达高于B10neg细胞,CXCL13优先吸引B10+细胞。
  • RA患者B细胞表面CXCR5水平降低,B10+细胞向富含CXCL13滑液的优先迁移丧失。
  • RA患者CXCL13刺激诱导的B细胞IL-10分泌少于健康供者。

核心结论

  • CXCR5/CXCL13轴是B10+细胞生物学所必需,但在RA患者中存在缺陷。
  • 恢复B10+细胞在受累关节内的优先迁移可能成为RA治疗策略的一部分。

研究设计与样本

  • 研究采用RNA测序和流式细胞术比较健康供者与RA患者B10+与B10neg细胞的趋化因子受体表达。
  • 评估B10+与B10neg细胞对重组趋化因子或滑液的迁移反应及B细胞IL-10分泌。

主要发现

  • CXCR5在B10+细胞表面表达水平高于B10neg细胞。
  • CXCL13优先吸引B10+细胞而非B10neg细胞。
  • RA患者滑液含高水平CXCL13,可诱导B10+细胞强烈且优先的迁移。
  • CXCL13可促进B细胞分泌IL-10。
  • RA患者B细胞表面CXCR5水平降低,B10+细胞向富含CXCL13滑液的优先迁移丧失,CXCL13刺激诱导的IL-10分泌少于健康供者。

临床怎么用

  • 监测RA患者B细胞CXCR5表达及CXCL13反应性可能有助于评估B10+细胞功能缺陷。
  • 靶向恢复B10+细胞向炎症关节的优先迁移或增强CXCL13诱导的IL-10分泌可能为RA治疗提供新思路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Chemokines (CKs) are key players of immune-cell homing and differentiation. CK receptors (CKRs) can be used to define T-cell functional subsets. We aimed to characterize the CKR profile of the regulatory B-cell subset B10+ cells and investigate the CKs involved in their migration and differentiation in healthy donors and patients with RA. METHODS: RNA sequencing and cytometry were used to compare CKR expression between B10+ and B10neg cells. Migration of B10+ and B10neg cells and IL-10 secretion of B cells in response to recombinant CKs or synovial fluid (SF) were assessed. RESULTS: CXCR5 was expressed at a higher level on the B10+ cell surface as compared with other B cells (referred to as B10neg cells). In line with this, its ligand CXCL13 preferentially attracted B10+ cells over B10neg cells. Interestingly, synovial fluid from RA patients contained high levels of CXCL13 and induced strong and preferential migration of B10+ cells. Besides its role in attracting B10+ cells, CXCL13 also promoted IL-10 secretion by B cells. In RA patients, the level of CXCR5 on B-cell surface was reduced. The preferential migration of RA B10+ cells toward CXCL13-rich SF was lost and CXCL13 stimulation triggered less IL-10 secretion than in healthy donors. CONCLUSION: Our results identify that the CXCR5/CXCL13 axis is essential for B10+ cell biology but is defective in RA. Restoring the preferential migration of B10+ within the affected joints to better control inflammation may be part of the therapeutic approach for RA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Rempenault C, Mielle J, Schreiber K, et al. CXCR5/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis. Rheumatology (Oxford). 2022. PMID: 34382069. doi:10.1093/rheumatology/keab639

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。